Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by B. Willms
Effects of Subcutaneous Glucagon-Like Peptide 1 (GLP-1 [7-36 Amide]) in Patients With NIDDM
Diabetologia
Internal Medicine
Endocrinology
Metabolism
Diabetes
Normalization of Fasting Hyperglycaemia by Exogenous Glucagon-Like Peptide 1 (7-36 Amide) in Type 2 (Non-Insulin-Dependent) Diabetic Patients
Diabetologia
Internal Medicine
Endocrinology
Metabolism
Diabetes
Related publications
Cardiovascular Effects of Glucagon-Like Peptide 1 (GLP-1) Receptor Agonists
Cardiovascular Diabetology
Internal Medicine
Cardiology
Endocrinology
Cardiovascular Medicine
Metabolism
Diabetes
Effects of Glucagon-Like Peptide-1(7-36)amide on Motility and Sensation of the Proximal Stomach in Humans
Gut
Gastroenterology
Glucagon-Like Peptide-1 Cleavage Product GLP-1(9-36) Amide Rescues Synaptic Plasticity and Memory Deficits in Alzheimer's Disease Model Mice
Journal of Neuroscience
Neuroscience
Radioimmunoassay for Glucagon-Like Peptide-1 in Human Plasma Using N-Terminal and C-Terminal Directed Antibodies: A Physiologic Insulinotropic Role Oe GLP-1( 7-36 Amide)
Biomedical Research
Biochemistry
Medicine
Genetics
Molecular Biology
Glucagon-Like Peptide-1 Receptor (GLP1R; GLP-1R)
Science-Business eXchange
Effect of Glucagon-Like Peptide 1(7-36) Amide on Glucose Effectiveness and Insulin Action in People With Type 2 Diabetes
Diabetes
Internal Medicine
Endocrinology
Metabolism
Diabetes
Effects of Glucagon-Like Peptide-1-(7–36)-Amide on Pancreatic Islet and Intestinal Blood Perfusion in Wistar Rats and Diabetic GK Rats
Clinical Science
Medicine
Glucagon-Like Peptide-1 Receptor (GLP-1R) Signaling Ameliorates Dysfunctional Immunity in COPD Patients
International Journal of COPD
Environmental
Public Health
Health Policy
Medicine
Pulmonary
Respiratory Medicine
Occupational Health
